Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2085 studies found for:    "Muscular Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
"Muscular Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy
Condition: Myopathy
Intervention:
2 Unknown  CoEnzyme Q10 in Statin Myopathy
Condition: Statin Myopathy
Interventions: Drug: CoEnzyme Q10;   Drug: Placebo
3 Completed Aerobic Training in Patients With Congenital Myopathies
Condition: Congenital Myopathy
Intervention: Other: Exercise on a cycle-ergometer
4 Active, not recruiting An Open Label Phase 2 Study of DEX-M74 in Subjects With GNE Myopathy
Condition: GNE Myopathy
Interventions: Drug: ManNac.;   Drug: ManNac
5 Completed A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Conditions: GNE Myopathy;   Hereditary Inclusion Body Myopathy
Interventions: Drug: Sialic Acid Extended Release (SA-ER);   Drug: Placebo
6 Completed Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)
Conditions: Hereditary Inclusion Body Myopathy (HIBM);   GNE Myopathy
Intervention: Drug: ManNAc
7 Recruiting Myotubular Myopathy Genetic Testing Study
Condition: Myotubular Myopathy
Intervention: Other: Genetic Testing
8 Recruiting Acceptance and Commitment Therapy for Muscle Disease
Condition: Muscle Diseases
Intervention: Behavioral: Acceptance and Commitment Therapy (ACT)
9 Recruiting RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR
Condition: MItochondrial Myopathies
Interventions: Drug: Omaveloxolone capsules, 2.5 mg;   Drug: omaveloxolone capsules, 5 mg;   Drug: omaveloxolone capsules, 10 mg;   Drug: Placebo capsules;   Drug: omaveloxolone capsules, 20 mg;   Drug: omaveloxolone capsules, TBD mg;   Drug: omaveloxolone capsules, 40 mg;   Drug: omaveloxolone capsules, 80 mg;   Drug: omaveloxolone capsules, 160 mg
10 Enrolling by invitation Treatment of TNNT1-Myopathy With L-Tyrosine.
Condition: Nemaline Myopathy
Interventions: Drug: L-Tyrosine;   Drug: Placebo
11 Completed Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design
Condition: Statin Myopathy
Intervention: Drug: Individual-specific statin causing myopathy
12 Active, not recruiting Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)
Condition: X-linked Myotubular Myopathy
Interventions: Other: History and physical;   Other: Tidal breathing;   Other: Maximal respiratory pressures;   Other: Peak cough flow;   Other: Pediatric Evaluation of Disability Inventory;   Other: PedsQL Multidimensional Fatigue Scale;   Other: Review of ventilation requirements
13 Recruiting Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)
Condition: Selenoprotein N-related Myopathy
Interventions: Drug: N-Acetylcysteine followed by Placebo;   Drug: Placebo followed by N-Acetylcysteine
14 Recruiting Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)
Condition: Myotubular Myopathy
Intervention:
15 Recruiting A Natural History Study of Patients With GNE Myopathy
Condition: Hereditary Inclusion Body Myopathy
Intervention:
16 Active, not recruiting Myotubular Myopathy Event Study
Condition: X-linked Myotubular Myopathy
Intervention:
17 Not yet recruiting Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy (CICS)
Condition: Recessive Gene Myopathies
Intervention:
18 Completed Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
Condition: Hereditary Inclusion Body Myopathy
Intervention: Drug: Immune Globulin
19 Terminated Metabolic Features of Post-Myopathy Patients Associated With Statin Treatment
Condition: Myopathy (Statin Associated)
Intervention:
20 Unknown  The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
Condition: Mitochondrial Myopathy
Intervention: Behavioral: Exercise

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.